» 2011

Animal Health News & Notes for November 11, 2011 11/11/2011

printer friendly version

************************************
Brakke Consulting's
Animal Health News & Notes for November 11, 2011
Copyright © Brakke Consulting, Inc.
 
Editor: Lynn Fondon, DVM MBA
************************************
IN THE NEWS:
 
Brakke news
Flea & Heartworm Markets report
AnimalHealthJobs.com
 
earnings news
Novozymes
Nutreco
 
other news
IDEXX
Boehringer Ingelheim Vetmedica
Merck
OncoPet Diagnostics
PetScreen
Pfizer
Tridelta Development
Webster (PURdigital)
Webster (OncoPet)
 
************************************
BRAKKE CONSULTING, INC.
COMING SOON:
US FLEA CONTROL & HEARTWORM MARKETS
2011 UPDATE
 
Brakke Consulting will soon be publishing our 2011 report on the US Flea Control and Heartworm Markets.  The report includes valuable information on the US market for small animal parasiticides including:
  - discussion of the impact of generic fipronil products
  - an overview of the veterinary and OTC flea control markets
  - Product descriptions, prices, and sales for the leading veterinary flea and heartworm products
  - 2011 survey of over 200 veterinarians
  - ALL NEW: For the first time, the report will include a survey of 500 pet owners regarding their usage of flea control products
 
The report on the US Flea Control & Heartworm Markets will be available for a purchase price of $6,995 if ordered by WEDNESDAY, NOVEMBER 23, and $7,500 after that date. 
 
Please contact Dr. Lynn Fondon at (972) 243-4033 or lfondon@brakkeconsulting.com to pre-order the report, or for more information visit our website at
 
www.BrakkeConsulting.com
 
************************************
COMPANY EARNINGS RELEASES
 
> Nutreco posted third quarter sales of EUR 1.54 billion ($2.15 billion), a 15% rise compared to the third quarter of 2010. (Animal Pharm)
 
> Novozymes reported results for the third quarter of 2011.  The feed enzymes division reported sales of DKK 349 million ($65 million), an increase of 12% compared to the same period of 2010 (17% excluding currency exchange effects). (Animal Pharm) 
 
************************************
COMPANY NEWS RELEASES
 
> Pfizer Animal Health announced the opening of the Pfizer Animal Health Equine Research Center in Richland, Michigan. The center is the culmination of a $7 million investment and will serve as the worldwide hub for research and development of equine vaccines and novel therapeutics. (TheHorse.com)
 
> Boehringer Ingelheim Vetmedica, Inc. announced it has received approval from the FDA to market Prascend (pergolide mesylate), for treatment of clinical signs associated with pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease. Prascend is the first and only FDA-approved product for the management of PPID in horses. (VetAdvantage) 
 
> IDEXX Laboratories, Inc. announced that it has acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri for $43 million in cash. RADIL serves the biomedical research community with veterinary laboratory diagnostics including serology, pathology, molecular diagnostics, microbiology, and parasitology. (company website)
 
> PetScreen and Tridelta Development announced the launch of the Tri-Screen Canine Lymphoma assay kit.  The test is able to differentiate between patients with lymphadenopathy due to lymphoma from lymphadenopathy due to other ailments such as lymphoid hyperplasia.  It will be available to reference laboratories. (PRNewswire)
 
> BioCurex Inc. announced that its wholly owned subsidiary, OncoPet Diagnostics, Inc., has signed a distribution agreement with Webster Veterinary Supply for the distribution of the OncoPet Sample Collection Kit for canine cancer diagnosis. (Globe Newswire)
 
> Webster Veterinary announced the launch of its exclusive line of PURdigital radiology products. This offering includes PURcr and PURdr, high-quality computed and digital radiography equipment; and PURpacs, a veterinary-specific image viewing and PACS platform. (company press release)
 
> EU  Merck Animal Health announced that it has received positive opinion from the CVMP in the European Union for Panacur AquaSol (fenbendazole), a suspension for use in drinking water indicated for the treatment and control of gastrointestinal nematodes. Panacur AquaSol is exclusive for swine. (company press release)
 
***********************************
ANIMAL HEALTH NEWS
 
> US - BOVINE TUBERCULOSIS   South Dakota animal health officials confirmed that a Hutchinson County cattle herd was infected with tuberculosis. An investigation is underway to determine whether other herds are affected. Two herds were affected in January 2010, but the state was allowed to keep its TB-Accredited-Free state status. South Dakota has been recognized by the USDA as a TB-Accredited-Free state since 1982. (RapidCityJournal.com)
 
> US ANTIBIOTIC USE   The FDA has denied a pair of petitions filed in 1999 and 2005 by the Center for Science in the Public Interest (CSPI) along with several environmental and medical organizations to limit the use of several antibiotics in farm animals.  In denying the 2005 petition, the FDA wrote that "FDA believes that the strategy set out in draft guidance #209 is a pathway to achieving the same goals as those advanced by your organization, i.e., judicious use of medically-important antimicrobials."  (CIDRAP)
 
*********************************
ANIMALHEALTHJOBS.COM
 
Now is the time to start looking for candidates you'll be hiring in early 2012. With over 16,000 registered job seekers on our recruiting web site, AnimalHealthJobs.com is the most efficient way to find qualified candidates with a minimum of effort.  Our ads run 90 days, giving you plenty of time before the Holidays to attain excellent results. A basic job posting is only $375.  Visit www.AnimalHealthJobs.com to find your next employee.
 
www.AnimalHealthJobs.com

***********************************
BRAKKE CONSULTING VIEWPOINT

The news this week ranges from new investments in R&D facilities to new companies entering the companion animal diagnostics business. These types of announcements are good for the industry.  New research facilities should mean new innovative products for the equine area in the future.  New diagnostics should help improve the early detection of animal diseases so they can be treated correctly and in a timely manner.  And we should not overlook the impact that new digital technology is bringing to veterinary practitioners in improving the health of their patients.
 
While animal health is sometimes referred to as the stepchild of the human pharmaceutical industry, one cannot overlook the important role the animal health companies play in increasing the safe supply of animal protein for human consumption and the improved health of our companion animals. Being an employee in animal health is a contribution to society and a benefit to your family.
 
I’m now back in Dallas after 4 weekends on the farm in South Dakota involved in the annual harvest of the ring-necked pheasant that seems to get smarter and wilder every year.  It’s the second year in a row that all three hunting parties that I hosted limited out!!  So, it was a good year and we left plenty for next year’s seed crop!!
 
Have a great weekend!!

Ron Brakke
 
************************************
Trouble viewing this newsletter?  You can view it online at www.BrakkeConsulting.com
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting's services and syndicated studies, visit our website at www.brakkeconsulting.com.
 
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA